83-07-8

应用筛选条件

关键词:'83-07-8'

显示 1-9 共 9 条结果关于 "83-07-8" 范围论文

Pharmacokinetics and bioavailability of valnemulin in Muscovy ducks (Cairina moschata).

J Sun et al.

British poultry science, 53(3), 374-378 (2012-09-18)

1. A pharmacokinetic study of valnemulin was conducted in healthy Muscovy ducks after intravenous (IV), intramuscular (IM) and oral administrations at a dose rate of 15 mg/kg body weight. 2. Drug concentrations in plasma were determined by high performance liquid

Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.

Bouthaina S Dabaja et al.

Cancer, 121(7), 1032-1039 (2014-12-11)

The role of consolidation radiotherapy was examined for patients with diffuse large B-cell lymphoma who were treated at institutions of the National Comprehensive Cancer Network during the rituximab era. Failure-free survival (FFS) and overall survival (OS) were analyzed in terms

Simultaneous determination of eight common odors in natural water body using automatic purge and trap coupled to gas chromatography with mass spectrometry.

Xuwei Deng et al.

Journal of chromatography. A, 1218(24), 3791-3798 (2011-05-14)

Production and fate of taste and odor (T&O) compounds in natural waters are a pressing environmental issue. Simultaneous determination of these complex compounds (covering a wide range of boiling points) has been difficult. A simple and sensitive method for the

Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis.

Matthias Hoke et al.

European journal of clinical investigation, 42(9), 921-926 (2012-03-29)

Humoral mediators of inflammation, in particular the complement system, have been described to play an important role in atherogenesis. Previously, we found a single-nucleotide polymorphism (SNP) in the complement 5 gene (C5 rs17611, A>G) independently associated with stroke. Up to

The impact of exercise frequency upon microvascular endothelium function and oxidative stress among patients with coronary artery disease.

Juliana P Borges et al.

Clinical physiology and functional imaging, 38(5), 840-846 (2017-12-28)

This study compared the effects of low and high weekly exercise frequencies on microvascular endothelium function and oxidative stress among patients with coronary artery disease. Thirty-four male patients completed a 6-month cardiac rehabilitation programme, from which 23 performed exercise with

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Oluwole Fadare et al.

Human pathology, 39(3), 331-336 (2008-02-12)

Analysis of gene expression profiling data on breast cancers has revealed "molecular subclasses" that may have prognostic significance. The "basal-like" breast cancers, one of these molecular subclasses, have been associated with a significantly worse overall and disease-free survival as compared

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Annemiek Broyl et al.

The Lancet. Oncology, 11(11), 1057-1065 (2010-09-25)

Bortezomib-induced peripheral neuropathy is a dose-limiting toxicity in patients with multiple myeloma, often requiring adjustment of treatment and affecting quality of life. We investigated the molecular profiles of early-onset (within one treatment cycle) versus late-onset (after two or three treatment

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.

Akira Tsuburaya et al.

The Lancet. Oncology, 15(8), 886-893 (2014-06-24)

The prognosis for locally advanced gastric cancer is poor despite advances in adjuvant chemotherapy. We did the Stomach cancer Adjuvant Multi-Institutional group Trial (SAMIT) to assess the superiority of sequential treatment (paclitaxel then tegafur and uracil [UFT] or paclitaxel then

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.

Raban V Jeger et al.

Lancet (London, England), 396(10261), 1504-1510 (2020-10-23)

In the treatment of de-novo coronary small vessel disease, drug-coated balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up to 12 months, but data beyond 1 year is sparse. We aimed to test the long-term efficacy and

1/1